文献速递MDS 与骨髓增殖性肿瘤

骨髓增生异常综合征患者报告结局核心集:EUMDS德尔菲研究

Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists.
PubMed 文献 · Blood Adv · 2022-01-01

该研究基于欧洲白血病网MDS注册组,通过文献检索获得40个候选患者报告结局(PRO),经两轮德尔菲调查(第一轮40例患者和38名血液科医生,第二轮38例患者和32名血液科医生)达成核心集共识。患者和医生共同选择「总体生活质量」为核心PRO,医生还选择「输血依赖负担」和「工作/日常活动能力」。两组对28个(第一轮)和19个(第二轮)PRO的评分存在统计学显著差异,总体评分相关性中等(Spearman相关系数=0.5,P<.05)。

要点

  • 患者与血液科医生共同确定「总体生活质量」为MDS核心PRO。
  • 血液科医生额外选择「输血依赖负担」和「工作/日常活动能力」为核心PRO。
  • 患者对「疾病知识」和「对医疗服务的信心」评分显著高于医生。

核心结论

  • 首次由患者和血液科医生共同达成MDS核心PRO集共识,为以患者为中心的日常实践和临床研究奠定基础。

研究设计与样本

  • 依据国际指南,通过全面文献检索识别候选PRO,最终选取40个PRO进行两轮德尔菲调查。
  • 第一轮参与者为40例MDS患者和38名血液科医生,第二轮为38例患者和32名医生。

主要发现

  • 患者和医生均选择「总体生活质量」为核心PRO,医生还选择「输血依赖负担」和「工作/日常活动能力」。
  • 第一轮有28个PRO、第二轮有19个PRO在患者与医生间评分差异有统计学意义(Mann-Whitney U检验;P<.05)。
  • 患者对「疾病知识」和「对医疗服务的信心」评分显著高于医生。
  • 两轮间两组总体平均PRO评分的相关性为中等(Spearman秩相关系数=0.5;P<.05)。
  • 第二轮德尔菲调查提高了PRO评分的一致性。

临床怎么用

  • 可将共识核心PRO集用于MDS日常实践和临床研究,促进以患者为中心的照护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patient-reported outcomes (PROs) are relevant and valuable end points in the care of patients with myelodysplastic syndromes (MDS). However, a consensus-based selection of PROs for MDS, derived by both patients and hematologists, is lacking. We aimed to develop a core set of PROs for patients with MDS as part of the prospective European LeukemiaNet MDS (EUMDS) Registry. According to international guidelines, candidate PROs were identified from a comprehensive literature search of MDS studies. Overall, 40 PROs were selected and evaluated in a two-round Delphi survey by 40 patients with MDS and 38 hematologists in the first round and 38 patients and 32 hematologists in the second round. Based on an agreement scale and predefined inclusion criteria, both patients and hematologists selected "general quality of life" as a core PRO. Hematologists also selected "transfusion-dependency burden" and "ability to work/activities of daily living" as core PROs. The second Delphi round increased PRO rating agreements. Statistically significant rating differences between patients and hematologists were observed for 28 PROs (Mann-Whitney U test; P < .05) in the first round and for 19 PROs in the second round, with "disease knowledge" and "confidence in health care services" rated notably higher by patients. The overall mean PRO ratings correlation between the 2 groups was moderate (Spearman's rank correlation coefficient = 0.5; P < .05). This first consensus on a core set of PROs jointly developed by patients and hematologists forms the basis for patient-centered care in daily practice and clinical research.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Stojkov I, Conrads-Frank A, Rochau U, et al. Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists. Blood Adv. 2022. PMID: 34492684. doi:10.1182/bloodadvances.2021004568

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。